Heyholder
‹ Back to the disclosure you were reading

GeneOne Life Science, Inc. Q3 operating loss of KRW 5.4 billion on revenue of KRW 1.8 billion

GeneOne Life Science, Inc.· Periodic Report

AI summary · Not investment advice

In Q3, the company sold KRW 1.8 billion and lost KRW 5.4 billion from its main business, versus a KRW 11.7 billion loss a year earlier.

Operating profit · 3 months

KRW -5.4 billion

Key facts

Revenue (3 months)
KRW 1.8 billion
Net income (3 months)
KRW -15.4 billion
Period
Q3 (cumulative 2026.01.01 ~ 2026.09.30)
Revenue (prior-year 3 months)
KRW 5.1 billion
Revenue (year to date)
KRW 6.4 billion
Operating profit (prior-year 3 months)
KRW -11.7 billion
Operating profit (year to date)
KRW -20.6 billion
Net income (prior-year 3 months)
KRW -11.5 billion
Net income (year to date)
KRW -36.7 billion

Earlier Periodic Report filings from this company

Filings of the same type
FiledTitleKey figure · Note
26.05.15[Amended] Periodic ReportKRW -2.3 billion

Comments

No comments yet

Comments from shareholders will appear here.